Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Efficacy Capital is a specialized life sciences investment firm that focuses on identifying and supporting high-potential companies within the biotechnology, pharmaceutical, and healthcare sectors. The firm employs a fundamental, research-driven approach to invest in both public and private entities that demonstrate strong clinical data and clear paths to commercialization. By leveraging deep industry expertise and a network of clinical advisors, Efficacy Capital aims to generate superior returns while advancing innovative medical solutions. Their portfolio typically includes companies working on transformative therapies across various therapeutic areas, including oncology, ophthalmology, and rare diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Efficacy Capital.